eaa777cd_CER_Inventory___CER_Inventory__Category
[Agency] AHRQ [Project Title] COST EFFECTIVENESS OF ANTICOAGULATION VERSUS GENETIC TESTING OF CYP2C9 & VKORC1 G [Institution] HOWARD UNIVERSITY [Amount] $0 [Summary] This study proposes using a simulation model of the natural history of VTE to determine the cost-effectiveness of genetic testing for CYP2C9 and VKORC1 genes to guide long-term use of warfarin anticoagulation from the societal perspective. Methodology: A decision analysis using discrete event simulation will be developed to construct an economic model depicting the health states of a cohort of patients as the disease evolves over time. Associated costs and quality of life traits (utilities) of the complications will be captured. [Completion/ Closing Date] 08/02/2010 [Link] link [Category] 
Medical treatments, items and services
CER Inventory | CER Inventory
Category